We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the potential effects of Meloxicam on liver health, including symptoms, risks, and preventive measures for Indian readers.

Meloxicam is a widely prescribed nonsteroidal anti-inflammatory drug (NSAID) used primarily to manage pain and inflammation associated with chronic arthritis, such as osteoarthritis and rheumatoid arthritis. While it offers significant relief for many, like all medications, it carries potential side effects. One area of concern for some individuals is its effect on the liver. This article aims to provide a comprehensive understanding of how meloxicam might affect liver health, focusing on information relevant to readers in India.
Meloxicam belongs to a class of drugs known as NSAIDs. These medications work by blocking the production of certain enzymes in the body that are responsible for creating inflammation. By reducing inflammation, meloxicam can effectively alleviate pain and stiffness in joints, improving mobility and quality of life for those suffering from arthritis. It is available by prescription only and is generally considered stronger than over-the-counter NSAIDs like ibuprofen, though it may take longer to achieve its full effect, making it more suitable for chronic pain management.
Inflammation is a natural response of the body to injury or infection, but in conditions like arthritis, it becomes chronic and damaging. Meloxicam targets specific enzymes, primarily cyclooxygenase-2 (COX-2), which play a key role in the inflammatory process. By inhibiting these enzymes, meloxicam reduces the production of prostaglandins, chemicals that cause pain, swelling, and fever. This mechanism helps to relieve the symptoms of arthritis, allowing individuals to carry out daily activities with less discomfort.
The liver is a vital organ responsible for metabolizing medications. While meloxicam is generally safe when taken as prescribed, it can, in rare instances, affect liver function. A potential side effect is a temporary increase in certain liver enzymes, such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Elevated levels of these enzymes in the blood can indicate that the liver is under stress or experiencing some form of injury.
It's important to note that these enzyme elevations are often minor and may resolve even if the medication is continued. In clinical trials, up to 15% of people taking meloxicam have experienced elevations of ALT or AST enzymes that are up to three times higher than normal levels. Increases less than three times the normal level are usually considered minor and often return to normal without any changes to the medication. A moderate increase, above three times the normal level, has been reported in about 1% of people. In such cases, a doctor might recommend stopping meloxicam or adjusting the dosage.
Severe liver damage directly attributed to meloxicam is extremely rare. However, like other NSAIDs, it carries a potential risk. The estimated rate of liver injury for all types of NSAIDs is between 1 to 9 people per 100,000. In a 2016 study examining 30 cases of NSAID-induced liver injury, 3 cases were linked to meloxicam. In these instances, liver injury developed within 13 to 24 days of starting the medication. There has also been a reported case of autoimmune hepatitis suspected to be triggered by meloxicam, a condition where the immune system mistakenly attacks the liver.
It is crucial to be aware of the warning signs that may indicate liver damage. If you experience any of the following symptoms while taking meloxicam, you should consult your doctor immediately:
In the reported cases of meloxicam-related liver injury, symptoms like jaundice, fever, and itchy rash were observed.
Certain individuals may be at a higher risk of experiencing liver problems or other complications from meloxicam. These include:
Meloxicam is generally not recommended for individuals with severe liver disease, kidney disease, or heart failure. Your doctor will assess your medical history and current health status to determine if meloxicam is a safe option for you.
If your doctor suspects that meloxicam might be affecting your liver, they may order blood tests to check your liver enzyme levels (AST and ALT). In some cases, especially for individuals at higher risk or those on long-term therapy, doctors may periodically monitor liver function even without specific symptoms. This proactive approach helps in detecting any potential issues early on.
If liver enzyme levels become significantly elevated or if symptoms of liver damage appear, the primary course of action is usually to stop taking meloxicam. In most cases, liver function improves rapidly once the medication is discontinued. Your doctor will guide you on the best alternative pain management strategies based on your specific condition and health status.
The best way to minimize the risk of liver problems associated with meloxicam is to:
You should consult your doctor immediately if you experience any of the symptoms of liver damage mentioned earlier. Additionally, seek medical advice if:
Meloxicam is an effective medication for managing arthritis pain, but like all drugs, it requires careful use. While the risk of significant liver damage is low, awareness of potential side effects and prompt medical attention if symptoms arise are crucial. Always consult your healthcare provider for personalized advice regarding meloxicam and your liver health.

Discover effective methods to remove and prevent stubborn blackheads on your nose. Learn about ingredients like salicylic acid, retinoids, and gentle cleansing routines suitable for Indian skin.
April 1, 2026
Learn effective ways to remove blackheads from your nose and prevent them with expert tips on cleansing, exfoliation, and skincare. Achieve clearer skin today!
April 1, 2026
Discover if pure aloe vera gel can effectively reduce the appearance of acne scars. Learn about its benefits, how to use it, and what results to expect.
April 1, 2026